Saltar al menú | Saltar al submenú | Saltar al contenido

Área de empleados pc | mobile     español | english
You are in: Home > News > Syva presents MARBOSYVA (injectable marbofloxacin)

News

18th December 2012

Syva presents MARBOSYVA (injectable marbofloxacin)

Laboratorios Syva increases its pharmaceutical product range with the launching of MARBOSYVA.

The product includes in its composition the active principle marbofloxacine at 10%, and it is available in the 100 and 250 ml presentations.

MARBOSYVA is indicated in cattle for the treatment of respiratory processes caused by Histophilus somni, Mannheimia haemolytica, Pasteurella multocida and Mycoplasma bovis, and also for the treatment of acture mastitis caused by E. coli.
Treatment with MARBOSYVA is very flexible. For respiratory infections you can choose between one single IM injection at a rate of 2 ml per 25 kg, or a daily IM or SC injection at a rate of 1 ml per 50 kg for 3 to consecutive 5 days. To treat acute mastitis in cattle you shall administer 1 ml per 50 kg for 3 to 5 consecutive days. In both indications, the first injection might be administered intravenously by the veterinary surgeon.

MARBOSYVA is indicated also for the treatment of the Metritis – Mastitis – Agalaxia syndrome in sows, at a rate of 1 ml per 50 kg body weight by IM route.

License Number: 2670-ESP (AEM Spain)

« back

DOCUMENTS

Laboratorios Syva S.A.U.
HEADQUARTERS: Av. Párroco Pablo Díez, 49-57 - 24010 León (Spain) - Tel. 987 800 800 - Fax 987 802 452
IMMUNOLOGICAL PLANT: Av. Portugal, s/n - Parc. M15 y M16 - Parque Tecnológico - 24009 León (Spain)
Facebook Twitter Youtube